Study: 2 good choices to prevent breast cancer
As a medical malpractice lawyer in Chicago, I am intrigued by the results of this new Breast Cancer study. Once proper and thoroughly testing is completed, the drug will hopefully make an impact on many lives. Marilynn Marchione reports, “A new study finds that two drugs are both good options for helping prevent breast cancer in older women at higher risk of developing the disease.” (AP Medical, 4/19).
Doctors assert that the drug tamoxifen can cut the risk of developing breast cancer in half. Additionally, a newer drug called raloxifene, which is sold as Evista, does nearly as well and is, according to testing, safer. Women on Evista had fewer cases of uterine cancer and other serious side effects.
Both drugs are already in use for different ailments: Tamoxifen is commonly used to treat breast cancer, and Evista used to treat osteoporosis. Doctors are hopeful the new study results will lead to wider usage of the drugs to prevent breast cancer in high risk patients.
Bookmark: 
